NorthWest Biotherapeutics Inc (NWBO)

[Margin Buu]

Thank you Hoffmann. There’s nothing left to do but wait for MAA APPROVAL. Period. Some people don’t want the clock to start but this is in the hands of the regulating authority.

What a monumental achievement by NWBO to make it to this milestone. Looking forward to a relatively swift approval by MHRA. GBM patients need this to be covered by insurance.

Exciting, from their last PR Dec 21st, GBM treatment is only the beginning:

The Company believes that this mechanism of action will be applicable for most types of solid tumors. Solid tumors comprise approximately 90% of all cancers, and a key difficulty that other treatment approaches have encountered with solid tumors is their heterogeneity.

The Company has already had positive results with DCVax-L in some compassionate use cases with other diverse solid tumors. The Company looks forward to building on its experience with DCVax-L in GBM and the compassionate use cases to address a wide range of other operable solid tumors.